MedicaidPrior AuthHigh impact
Prior Authorization of Neuropathic Pain Agents MAB 01-19-73
Pennsylvania Medicaid (DHS)·PA · Pain Management, Neurology, Family Medicine +2 more·Prior Authorization
Effective date
Jan 1, 2020
We identified it
Jun 20, 2026
Summary
Pennsylvania Medicaid now requires prior authorization for neuropathic pain agents (gabapentin, pregabalin) when there's therapeutic duplication, plus new requirements for controlled substance PDMP searches and FDA-compliant dosing documentation.
Action Required
Before January 1, 2020: Billing team must update prior authorization workflows for neuropathic pain agents (gabapentin, pregabalin) to include PDMP search documentation for controlled substances and therapeutic duplication screening. Providers must document FDA-approved dosing and conduct PDMP searches before prescribing controlled neuropathic pain agents. Update encounter forms and EMR templates to capture required documentation elements. Claims without proper prior authorization will be denied.